ALPAT.PA
Get informed when a big investor buys or sells
+ FollowOvervalued by 103.3% based on the discounted cash flow analysis.
| Market cap | $4.81 Million |
|---|---|
| Enterprise Value | $8.50 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $0.51 |
| Beta | 0.81 |
| Outstanding Shares | 1,124,000 |
| P/E Ratio | 8.27 |
|---|---|
| PEG | 0.47 |
| Price to Sales | 2.0 |
| Price to Book Ratio | 0.5 |
| Enterprise Value to Revenue | 3.01 |
| Enterprise Value to EBIT | -11.62 |
| Enterprise Value to Net Income | 13 |
| Total Debt to Enterprise | 0.44 |
| Debt to Equity | 0.38 |
No data
No data available for the latest quarter.
No data available for the latest quarter.
No data
Plant Advanced Technologies SA, a plant biotechnology company, produces and sells actives for cosmetic, pharmaceutical, and agrochemical markets in France. Its technologies include Process PAT Exudactive a sustainable sourcing solution t...